Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Ivana Kyung Kim, M.D.

Co-Author

Back to Details
This page shows the publications co-authored by Ivana Kim and Jeffrey Heier.
Ivana Kim
Connection Strength
0.670
Jeffrey Heier
  1. Ranibizumab for choroidal neovascularization secondary to causes other than age-related macular degeneration: a phase I clinical trial. Ophthalmology. 2011 Jan; 118(1):111-8.
    View in: PubMed
    Score: 0.444
  2. Risk of Inflammation, Retinal Vasculitis, and Retinal Occlusion-Related Events with Brolucizumab: Post Hoc Review of HAWK and HARRIER. Ophthalmology. 2021 07; 128(7):1050-1059.
    View in: PubMed
    Score: 0.226
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.